et al., in BMJ, Vol. 384, Article No. e076410. Published online January 29, 2024 Tirzepatide: a Two

either semaglutide (which is sold under brand names such as Ozempic and Wegovy) or tirzepatide (sold as Mounjaro and

GLP-1) drug —these include semaglutide, which is sold as Wegovy and Ozempic, or tirzepatide, which is sold as

treatment of obesity has been revolutionized by new drugs such as semaglutide and tirzepatide. In clinical

lose weight. For extra punch, Eli Lilly developed a “dual agonist” called tirzepatide (sold as Zepbound for

here’s why Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to

GLP-1 sold as Wegovy and Ozempic, for example) and tirzepatide (sold as Zepbound and

semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (the active

seems to boost the medications’ weight-loss effects. For example, tirzepatide (sold under the

of Zepbound and Mounjaro, which are the brand name for tirzepatide. And so

And in another clinical trial, injections of 15-mg doses of tirzepatide (the active

to look at not only GLP-1 receptor agonists but also other gut hormones, including GIP. Tirzepatide, the active

And in another clinical trial, injections of 15-mg doses of tirzepatide (the active

for blood sugar and weight loss compared with previous trials of tirzepatide (which targets two receptors

1 Pills Are Here Blockbuster weight-loss medications such as Wegovy (semaglutide) and Zepbound (tirzepatide) have been in

of three weight-loss medications — Wegovy, the KwikPen version of Zepbound (tirzepatide) and Foundayo

in March to test it against a placebo and tirzepatide — sold as Mounjaro and

here’s why Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to

multiple organs. GLP-1 drugs might also act on tumors directly. In animal studies , tirzepatide—the dual

longer and eat less. Newer versions of GLP-1 drugs, such as tirzepatide (sold as Zepbound and

to be approved for treating obesity. Today, newer variants, including semaglutide and tirzepatide, sold as Wegovy and

them GLP-1s. And these are the drugs like semaglutide, liraglutide, exenatide, tirzepatide—the “-atides

the rate. In another study from 2023 in which people were given tirzepatide—a newer

form of semaglutide used to treat type 2 diabetes), Zepbound (known generically as tirzepatide) and other

pathways. And very, very early study results show that it’s even more effective than tirzepatide, which is the

to look at not only GLP-1 receptor agonists but also other gut hormones, including GIP. Tirzepatide, the active